Where can I find news about CRT?

Press releases, SEC filings, and prospectus updates from the fund issuer are listed on this page. Cross Timbers Royalty Trust (CRT) news is sourced from regulatory filings and the issuer's investor relations feed.

How can I track CRT's SEC filings?

CRT's 485APOS / 485BPOS prospectus filings, N-CSR shareholder reports, and other regulatory filings are listed on this page with direct links to the SEC EDGAR copies. Filings update as the issuer submits them — typically semi-annually for shareholder reports.

Where can I find CRT's prospectus?

Cross Timbers Royalty Trust (CRT)'s most recent prospectus is linked in the filings section on this page. Issuers publish the full prospectus on their product page and re-file it annually with material updates flagged in the 485BPOS amendment.

CRT

Cross Timbers Royalty Trust

NYSE·Oil & Gas Exploration & Production · Energy

$9.76$0.11+1.09%

Jul 23 3:52 PM UTC

Press Releases

CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION
DALLAS, July 21, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.061397 per unit, payable on August 14, 2026, to unitholders of record on July 31, 2026. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.
prnewswire.comJul 21, 2026 · 8:00 AM
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Speciali
gurufocus.comJul 18, 2026 · 3:00 PM
CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION
DALLAS, June 18, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.044186 per unit, payable on July 15, 2026, to unitholders of record on June 30, 2026. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.
prnewswire.comJun 18, 2026 · 8:00 AM
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
gurufocus.comMay 29, 2026 · 7:00 AM
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the
gurufocus.comMay 28, 2026 · 10:00 PM
CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION
DALLAS, May 18, 2026 /PRNewswire/ -- Argent Trust Company, as Trustee of the Cross Timbers Royalty Trust (the "Trust") (NYSE: CRT), today declared a cash distribution to the holders of its units of beneficial interest of $0.029624 per unit, payable on June 12, 2026, to unitholders of record on May 29, 2026. The following table shows underlying oil and gas sales and average prices attributable to the current month and prior month distributions.
prnewswire.comMay 18, 2026 · 8:00 AM
The Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It
[key points] Oil is back in the headlines, and royalty trusts are quietly soaking up the rebound.
247wallst.comMay 14, 2026 · 12:05 PM
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (âInnateâ or the âCompanyâ) today reported its business update and consolidated
gurufocus.comMay 13, 2026 · 2:00 AM

Fund Documents

SEC filings for CRT aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.

Frequently Asked Questions About CRT

Where can I find news about CRT?: Press releases, SEC filings, and prospectus updates from the fund issuer are listed on this page. Cross Timbers Royalty Trust (CRT) news is sourced from regulatory filings and the issuer's investor relations feed.
How can I track CRT's SEC filings?: CRT's 485APOS / 485BPOS prospectus filings, N-CSR shareholder reports, and other regulatory filings are listed on this page with direct links to the SEC EDGAR copies. Filings update as the issuer submits them — typically semi-annually for shareholder reports.
Where can I find CRT's prospectus?: Cross Timbers Royalty Trust (CRT)'s most recent prospectus is linked in the filings section on this page. Issuers publish the full prospectus on their product page and re-file it annually with material updates flagged in the 485BPOS amendment.

Cross Timbers Royalty Trust

Frequently Asked Questions About CRT

Cross Timbers Royalty Trust

CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting

CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION

The Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Frequently Asked Questions About CRT

CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting

CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION

The Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results